Latest Anxiolytics Stories
By Bill Berkrot NEW YORK (Reuters) - An experimental insomnia drug being developed by Merck & Co. and Danish drug maker H. Lundbeck A/S showed promise in helping patients achieve deep sleep in small mid-stage clinical studies, the companies said on Wednesday.
The burgeoning ethanol industry is changing the economic landscape of rural America, as companies pour billions of dollars into production plants in a race to meet demand and ease America's addiction to gasoline.
U.S. Rep. Patrick Kennedy's statement that he used Sanofi-Aventis's sleep drug Ambien, to explain how he might have been involved in a late-night car crash, has led to renewed attention on the drug's possible side-effects.
Strange behavior by insomniacs taking prescription drugs, ranging from binge eating to having sex while asleep, have raised safety questions about anti-insomnia medications like Sanofi-Aventis' Ambien.
NEW YORK (Reuters Health) - A program designed to reduce inappropriate prescriptions for benzodiazepines, such as Xanax and Valium, had the unintended consequence of increasing racial disparities in access to care, according to a report in the Archives of Internal Medicine.
No single sleeping pill stands out as the best, according to a U.S. review of the newer sleep aids on the market.
NEW YORK (Reuters Health) - While sedative drugs, such as Restoril and Ambien, may improve sleep in older people with insomnia, the risks of such therapy may outweigh the benefits, according to investigators in Canada.
Researchers outline five basic steps to help doctors identify and treat insomnia in elderly patients. This article is published in a special insomnia themed supplement of the Journal of the American Geriatrics Society.
The investigational drug ramelteon reduced the time it took for people with chronic insomnia to fall asleep and also increased their total sleep time, according to the results of a Phase III study sponsored by the drug's maker, Takeda Pharmaceuticals.
Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time in adults with chronic insomnia, according to results from a Phase 3 study presented this week at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS). Results of the study also showed no evidence of rebound insomnia, next-day impairments or withdrawal effects due to discontinuation.
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.